GlassScriptPhysician profile
Alpna Mullick
NPI 1285622837
$1,780.23
in general payments reported to CMS, 2019-2025
15 companies · $304 in 2025
The $304 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $210 · 2021: $18.96 · 2022: $153 · 2023: $310 · 2024: $284 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $416.36 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $277.35 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $203.45 | 2019-2025 | Bexsero |
| Alk-Abello, INC | $197.37 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Sanofi Pasteur INC. | $155.08 | 2019-2025 | |
| Pfizer INC. | $147.58 | 2020-2024 | |
| Ironshore Pharmaceuticals INC. | $124.05 | 2019-2024 | |
| Cranial Technologies, INC | $92.11 | 2022-2024 | Doc Band |
| Biomarin Pharmaceutical INC. | $37.30 | 2023-2025 | Voxzogo 1.2mg |
| Sobi, INC | $36.99 | 2019-2023 | |
| Corium, LLC | $23.84 | 2024 | Azstarys |
| Seqirus USA INC | $20.62 | 2024 | Flucelvax |
| Collegium Pharmaceutical, INC. | $18.83 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $15.18 | 2025 | Qelbree |
| Otsuka America Pharmaceutical, INC. | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpna Mullick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.